Serina Therapeutics, Inc.SERNYSE
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+388.2%
5Y CAGR+120.4%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+388.2%/yr
Quarterly compound
5Y CAGR
+120.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
52x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 1629.19% |
| Q2 2025 | -18.50% |
| Q1 2025 | -15.30% |
| Q4 2024 | -97.66% |
| Q3 2024 | -3.82% |
| Q2 2024 | 5.37% |
| Q1 2024 | 206.20% |
| Q4 2023 | 66.52% |
| Q3 2023 | -93.28% |
| Q2 2023 | 9.84% |
| Q1 2023 | 65.82% |
| Q4 2022 | 15.84% |
| Q3 2022 | 14.00% |
| Q2 2022 | 26.31% |
| Q1 2022 | -17.70% |
| Q4 2021 | 15.74% |
| Q3 2021 | 25.02% |
| Q2 2021 | 24.07% |
| Q1 2021 | 16.80% |
| Q4 2020 | 14.00% |
| Q3 2020 | 31.34% |
| Q2 2020 | 101.00% |
| Q1 2020 | 6.95% |
| Q4 2019 | 160.80% |
| Q3 2019 | 84.28% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |